In June of 2018, the FDA approved, for the first time, a cannabis based drug. Epidiolex, is a CBD drug used to treat Dravet Syndrome.

The post Months After FDA Acceptance, CBD Drug Epidiolex Gains DEA Approval appeared first on Medical Marijuana 411.



Source link